Relative Bioavailability of Olodaterol and Fluconazole

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Conditions
HealthyPulmonary Disease, Chronic Obstructive
Interventions
DRUG

BI 1744

10 mcg solution for oral inhalation

DRUG

Fluconazole

400 mg capsule

Trial Locations (1)

Unknown

1222.48.1 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY